Details of Disease

General Information of Disease (ID: DISKD4Y8)

• Disease Name: Psoriatic disorder
• Disease Class: EA90: Psoriasis
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISKD4Y8: Psoriatic disorder
• ICD Code:
  ICD-11: ICD-11: EA90
  ICD-9: ICD-9: 696
  Expand ICD-11: 'EA90
  Expand ICD-10: 'L40; 'L40.8; 'L40.9
  Expand ICD-9: 696

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Teriparatide	DMMC45B	Approved	Peptide	[1]

This Disease is Treated as An Indication in 3 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Bimosiamose	DM0TH9A	Phase 2a	Small molecular drug	[2]
AN0128	DMT3S10	Phase 2	Small molecular drug	[3]
IR502	DMW2IF9	Phase 2	NA	[4]

This Disease is Treated as An Indication in 5 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
ASF-1075	DM0WYRR	Discontinued in Phase 2	NA	[5]
CRx-191	DMB9QSJ	Discontinued in Phase 2	NA	[6]
T487	DMZTL7H	Discontinued in Phase 2	Small molecular drug	[7]
VTP-201227	DMFYM61	Discontinued in Phase 2	NA	[8]
CRA-028129	DMRNB7V	Terminated	NA	[10]

This Disease is Treated as An Indication in 1 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
ATL-1101	DM4XZU2	Preclinical	Antisense drug	[9]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030730)
• [2] Emerging drugs for asthma. Expert Opin Emerg Drugs. 2008 Dec;13(4):643-53.
• [3] Clinical pipeline report, company report or official report of Anacor Pharmaceuticals.
• [4] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008880)
• [5] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024080)
• [6] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025635)
• [7] Clinical pipeline report, company report or official report of ChemoCentryx.
• [8] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022961)
• [9] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020853)
• [10] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022029)